Attention deficit hyperactivity disorder (ADHD) is one of the most commonly diagnosed childhood psychiatric disorders manifested in almost every part of children’s behavior. The most common treatment of ADHD is medication with stimulants, by specific amphetamine and methylphenidate. It is known that the treatment by stimulants may be accompanied by side effects from among decrease of appetite or changes in development as growth suppression and loss of weight which may present very serious phenomenon. Although many studies have monitored changes in growth and weight during medication, they did not provide definite results that the growth and weight suppression are caused by medication or not. According to many studies the height deficit is approximately amounted to 1 cm/year during the first 3 years of the treatment and can be clinically serious. Contrary to these findings some authors reported that the growth or weight changes can be a natural symptom of ADHD and not just a consequence of medication. The present article reviews key studies monitoring changes in parameters of growth in medicated children with ADHD, compares their results and suggest methodology improvements for further studies.
Barkley, R., A., DuPaul, G., J., & Connor, D. (1999). Stimulans. In J. S. Werry & M. Aman (Eds.), Practitioners guide to psychoactive drugs with children and adolescents (2nd ed.). New York: Plenum.
Barkley, R., A. & Macias, M. (2005). Attention deficit hyperactivity disorder. In R. David (Ed.) Child and adolescent neurology (3rd ed.). New York: Blackwell.
Biederman, J., Faraone, S., V., & Monuteaux, M., C., et al. (2003). Growth deficits and attention-deficit/hyperactivity disorder revisited: impact of gender, development and treatment. Pediatrics, 111, 1010–16.
Charach, A., Figueroa, M., & Chen, S., Ickowicz, A., Cha-char, R. (2006). Stimulant Treatment Over 5 Years: Effects on Growth. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 415–421.
Curtin, C., Bandini, L., G, & Perrin, E., C., Tybor, D., J., Must, A. (2005). Prevalence of overweight in children and adolescents with attention deficit hyperactivity disorder and autism spectrum disorders: a chart review. BMC Pediatrics, 5, 48.
Drappatz, J., Khwaja, O., S., & Neovius, M., Sarco, D., S. (2006). Growth in Children with AD(H)D Treated with Stimulant Medications: A Meta-Analysis. Pediatric Academic Societies Annual Meeting, 4885458.
Drtilkova, I. (2003). Ucinnost nestandardnich postupu lecby u deti s ADHD. [Effect on non-standard approaches to ADHD treatement]. Ceska a slovenska Psychiatrie, 99, 317–323.
Faraone, S. & Giefer, E. (2007). Long-Term Effects of Methylphenidate Transdermal Delivery System Treatment of ADHD on Growth. Journal of the American Academy of Child & Adolescent Psychiatry, 46, 1138–1147.
Faraone, S., V., Biederman, J., & Morley, C., Spencer, T., J., (2008). Effect of stimulants on height and weight: a review of the literature. Journal of the American Academy of Child and Adolescent Psychiatry, 47, 994–1009.
Fassbender, C. & Schweitzer, J., B. (2006). Is there evidence for neural compensation in attention deficit hyperactivity disorder? A review of the functional neuroimaging literature. Clinical Psychology Review, 26, 445–65.
Friedmann, N, Thomas, J., & Carr, R., Elders, J., Ringhdahl, J., Roche, A. (1981). Effect on growth in pemoline-treated children with attention deficit disorder. American Journal of Diseases of Children, 135, 329–332.
Jensen, P., S. (2009). Review: methylphenidate and psychosocial treatments either alone or in combination reduce ADHD symptoms. Evidence-Based Mental Health, 12, 783–800.
Kaiser, N., M., Hoza, B., & Hurt, E., A. (2008). Multimodal treatment for childhood attention-deficit/hyperactivity disorder. Expert Review of Neurotherapeutics, 8, 1573–83.
Kalachnik, J., E., Sprague, R., L., & Sleator, E., K., et al. (1982). Effect of methylphenidate hydrochloride on stature of hyperactive children. Developmental Medicine & Child Neurology, 24, 586–95.
Klein, R., G., Landa, B., & Mattes, J., A., et al. (1988). Methylphenidate and growth in hyperactive children. A controlled withdrawal study. Archives of General Psychiatry, 45, 1127–30.
Kramer, J., R., Loney, J., & Ponto, L., B., et al. (2000). Predictors of adult height and weight in boys treated with methylphenidate for childhood behavior problems. Journal of the American Academy of Child and Adolescent Psychiatry, 39, 517–24.
Kratochvil, C., J., Wilens, T., E., & Greenhill, L., L., et al. (2006). Effects of long-term atomoxetine treatment for young children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 919–27.
Lisska, M., C. & Rivkees, S., A. (2003). Daily methylphenidate use slows the growth of children: a community based study. Journal of Pediatric Endocrinology & Metabolism, 16, 711–8.
Mattes, J., A. & Gitelmann, R. (1983). Growth of hyperactive children on maintenance regimen of methylphenidate. Archives of General Psychiatry, 40, 317–21.
McAfee, A., T., Holdridge, K., C., & Johannes, C., B., Hornbuckle, K., Walker, A., M. (2008). The effect of pharmacotherapy for attention deficit hyperactivity disorder on risk of seizures in pediatric patients as assessed in an insurance claims database. Current Drug Safety, 3, 123–31.
Millichap, J., G. & Millichap, M. (1975). Letter: Growth of hyperactive children. The New England Journal of Medicine, 292, 1300.
Millichap, J., G., (1978). Growth of Hyperactive Children Treated with Methylphenidate. Journal of Learning Disabilities, 11, 567–570.
MTA Cooperative Group, (2004). National Institute of Mental Health Multimodal Treatment Study of ADHD Follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics, 113, 762–9.
Paclt, I., Ptacek, R., & Florian, J. (2006). Hyperaktivita [Hyperactivity]. Praha: Vzdelavaci institut ochrany deti.
Paclt I. & Florian J. (1996). Deficit pozornosti u hyperaktivnich deti [Deficit of attention in hyperactive children]. Ceska a slovenska psychiatrie, 1, 23–40.
Paclt I., Uhlikova P., & Koudelova J., Bauer P., Vaneckova M. et al. (2000). Biological markers of the hyperkinetic syndrome in children of age 6 to 10 years. European Psychiatry, 75, 385.
Paclt, I. (2008). Hyperkyneticka porucha chovani [ADHD]. Praha: Grada.
Pliszka, S., R., Matthews, T., L., & Braslow, K., J., Watson, M., A. (2006). Comparative effects of methylphenidate and mixed salts amphetamine on height and weight in children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 45 (5), 520–6.
Poulton, A. & Cowell, C., T. (2003) Slowing of growth in height and weight on stimulants: a characteristic pattern. Journal of Paediatric and Children Health, 39, 180–5.
Poulton, A. (2005). Growth on stimulant medication; clarifying the confusion: a review. Archives of General Psychiatry, 90, 801–806.
Poulton, A. (2007). Effect of long-term treatment with stimulant medication on growth? Journal of American Acadady of Child and Adolescent Psychiatry, 46, 305–6.
Poulton, A., S. & Nanan, R. (2008). Prior treatment with stimulant medication: a much neglected confounder of studies of growth in children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 18, 385–7.
Ptacek, R., Kuzelova, H, & Paclt, I., Zukov, I. (2008). Effect of medication on anthropometric characteristic of ADHD children. Ceska a Slovenska Psychiatrie, 704, 415–419.
Prihodova, I. & Nevsimalova, S. (2006). Spanek a porucha pozornosti s hyperaktivitou — souhrn soucasnych poznatku [Sleep and ADHD — review]. Ceska a slovenska Psychiatrie, 102, 80–84.
Rao, J., K., Julius J., R., & Breen, T., J., Blethen, S., L. (1998). Response to Growth Hormone in Attention Deficit Hyperactivity Disorder: Effects of Methylphenidate and Pemoline Therapy. Pediatrics, 102, 497–500.
Roth, R., M. & Saykin, A., J. (2004). Executive dysfunction in attention-deficit/hyperactivity disorder: cognitive and neuroimaging findings. The Psychiatric Clinics of North America, 27, 83–96.
Safer, D., J., Allen, R., P., & Barr, E. (1972). Depression of growth in hyperactive children on stimulant drugs. The New England Journal of Medicine, 287, 217–220.
So, C., Y., Leung, P., W., & Hung, S., F. (2008). Treatment effectiveness of combined medication/behavioural treatment with Chinese ADHD children in routine practice. Behaviour Research Therapy, 46, 983–92.
Satterfield, J., H, Cantwell, D., P., & Schell, A., Blaschke, T. (1979). Growth of hyperactive children treated with methylphenidate. Archives of General Psychiatry, 36, 212–217.
Schertz, M., Adesman, A., R., & Alfieri, N., E., Bienkowski, R., S., (1996). Predictors of weight loss in children with attention deficit hyperactivity disorder treated with stimulant medication. Pediatrics, 98, 4 (1), 763–9.
Setoodeh, A. & Teleffson, S., (2007). Attention Deficit Hyperactivity Disorder and Growth. Iranian Journal od Pediatrics, 17, 183–187.
Shashank, V. & Joshi, M., D. (2002). ADHD, Growth Deficits, and Relationships to Psychostimulant Use Pediatrics in Review. Henry M. Adam, MD, Editor, In Brief, 23, 67–68.
Spencer, T., Biederman, J., & Wilens, T. (1998). Growth deficits in children with attention deficit hyperactivity disorder. Pediatrics, 102, 501–506.
Sund, A., M. & Zeiner, P. (2002). Does extended medication with amphetamine or methylphenidate reduce growth in hyperactive children? Nordic Journal of Psychiatry, 56, 53–7.
Swanson, J., M., Sergeant, J., A., & Taylor, E., Sonuga-Barke, E., I., S., Jensen, P., S., Cantwell, D., P. (1998). Attention-deficit Hyperactivity Disorder and Hyperkinetic Disorder. The Lancet, 557, 429–433.
Swanson, J., Greenhill, L., L., & Wigal, T., Kollins, S., H., Stehli-Nguyen, A., Davies, M., Chuang, S., Vitiello, B., Skrobala, A., M., Abikoff, H., Oatis, M., McCracken, J., Mc-Gough, J., J., Riddle, M., Ghuman, J., Cunningham, C., Wigal, S. and the PATS Group (2006). Stimulant-Related Reductions of Growth Rates in the PATS. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 1304–13.
Vaidya, C. J. & Stollstorff, M. (2008). Cognitive neuroscience of Attention Deficit Hyperactivity Disorder: current status and working hypotheses. Developmental Disabilities Research Reviews, 14, 261–1.
Vincent, J., Varley, C., K., & Leger, P., (1990). Effects of methylphenidate on early adolescent growth. The American Journal of Psychiatry, 147, 501–2.
Waring, M., E. & Lapane, K., L. (2008). Overweight in Children and Adolescents in Relation to Attention-Deficit/Hyperactivity Disorder: Results From a National Sample. Pediatrics, 122, e1–e6.
Zachor, D., A., Roberts, A.,W., & Hodgens, J., B., Isaacs, J., S., Merrick, J. (2006). Effect of long-term psychostimulant medication on growth of children with AD(H)D. Research of Developmental Disabilities, 27, 162–74.
Zhang, H., Du., M., Zhuang., S., & Liu, M., (2005) Influence of methylphenidate on growth of school age children with attention deficit hyperactivity disorder. Zhonghua Er Ke Za Zhi. Chinese Journal of Pediatrics. 43, 723–5.
About this article
Cite this article
Ptacek, R., Kuzelova, H. & Paclt, I. Effect of Stimulants on Growth of ADHD Children: A Critical Review. Act Nerv Super 51, 140–146 (2009). https://doi.org/10.1007/BF03379556
- Attention disorders